http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1524975-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfae81468523c4a7e635145a1bfe2359
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2003-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_277b17b65964185310cc6b24d0ba6363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f5cf787f98ff645f48450adb24bb14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fce73f9dd654f3d12b91b5acf96f0bf0
publicationDate 2005-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1524975-A1
titleOfInvention Improved transdermal delivery system for the administration of rotigotine
abstract An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid semi-permeable polymer (1) wherein rotigotine in its free base form has been incorporated, (2) which is saturated with rotigotine and contains said rotigotine as a multitude of microreservoirs within the matrix, (3) which is highly permeable for the free base of rotigotine, (4) which is impermeable for the protonated form of rotigotine, (5) wherein the maximum diameter of the microreservoirs is less than the thickness of the matrix. is provided. Said TDS provides for enhanced flux of rotigotine across the TDS/skin interface.
priorityDate 2002-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227918836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18598488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129721219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54481357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9953598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54680660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19840482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128375599

Total number of triples: 37.